Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions

Journal of the National Cancer Institute

Volumn 89, Issue 15, 1997, Pages 1161-1163

  Gallo, Oreste ^a   Santucci, Marco ^a   Franchi, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; ONCOPROTEIN; PROTEIN P16; PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; LARYNX TUMOR; MALE; MALIGNANT TRANSFORMATION; ONCOGENE; PATIENT MONITORING; PRECANCER; PROGNOSIS; TUMOR SUPPRESSOR GENE; VOCAL CORD;

EID: 0030749645     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.15.1161     Document Type: Article

References (15)

1. Weinstein IB. The origin of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment - twenty-seventh G. H. A. Clowes memorial award lecture. Cancer Res 1988; 48:4135-43.
2. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994;12:851-73.
3. Bouquot JE. Epidemiology. In: Gnepp DR, editor. Pathology of the head and neck. New York: Churchill-Livingstone, 1988:263-314.
4. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61: 759-67.
5. Friedmann I. Precursors of squamous cell carcinoma. In: Ferlito A, editor. Surgical pathology of laryngeal neoplasms. 1st ed. London: Chapman & Hall, 1996:107-21.
6. Geradts J, Wilson PA. High frequency of aberrant p16(INK4A) expression in human breast cancer. Am J Pathol 1996;149:15-20.
7. Barbatis C, Loukas L, Grigoriou M, Nikolau I, Tsikou-Papafragou A, Marsan N, et al. p53 overexpression in laryngeal squamous cell carcinoma and dysplasia. J Clin Pathol 1995; 48:M194-7.
8. Calzolari A, Chiarelli I, Bianchi S, Messerini L, Gallo O, Porfirio B, et al. Immunohistochemical versus molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer. Am J Clin Pathol 1997;107:7-11.
9. Loughran O, Malliri A, Owens D, Gallimore PH, Stanley MA, Ozanne B, et al. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene 1996;12: 561-8.
10. INK4a in oral premalignant lesions. Oncogene 1997;14:1799-803.
11. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
12. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996;2: 682-5.
13. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, et al. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci U S A 1996; 93:9770-5.
14. Hong WK, Lippman SM, Hittelman WN, Lotan R. Retinoid in the chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin Cancer Res 1995;1:677-86.
15. Issing WJ, Struck R, Naumann A. Long-term follow-up of larynx leukoplakia under treatment with retinyl palmitate. Head Neck 1996;18:560-5.